Author:
M. Garcia-Gutierrez Carlos,Becerra-Herrejon Habid,A. Garcia-Becerra Carlos,Garcia-Becerra Natalia
Abstract
The minimally invasive, image-guided therapies are a clear option in the urologists’ armamentarium to treat BPH and prostate cancer. During the last decade, advances in the HIFU systems improved the capacities to scan, fuse MR images to target a specific zone, situation that improved the safety and possibility to ablate the cancer in a focalized location or a whole gland ablation, preserving continence and erections, with a proper selection of patients, with good results, comparable with surgery or radiation. In some post radiation failures, it is a very safe option to treat the recurrent cancer. In the case of BPH, the flexibility to ablate exclusively the prostate enlargement, preserving the urethra is a great advantage, considering a fast procedure, no bleeding, and a highly precise treatment, with improvement in the voiding function, improving IPSS and uroflowmetry parameters.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献